CUAMC
RVNC
China Universal Asset Management Company’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,243
| Closed | -$67.6K | – | 509 |
|
|
2024
Q4 | $67.6K | Buy |
22,243
+2,082
| +10% | +$6.33K | 0.01% | 430 |
|
|
2024
Q3 | $105K | Buy |
20,161
+7,890
| +64% | +$40.9K | 0.01% | 354 |
|
|
2024
Q2 | $31.5K | Sell |
12,271
-4,710
| -28% | -$12.1K | ﹤0.01% | 382 |
|
|
2024
Q1 | $83.5K | Buy |
16,981
+6,826
| +67% | +$33.6K | 0.01% | 387 |
|
|
2023
Q4 | $89.3K | Buy |
10,155
+7,905
| +351% | +$69.5K | 0.02% | 297 |
|
|
2023
Q3 | $25.8K | Buy |
2,250
+1,148
| +104% | +$13.2K | 0.01% | 284 |
|
|
2023
Q2 | $27.9K | Sell |
1,102
-20
| -2% | -$506 | 0.01% | 238 |
|
|
2023
Q1 | $36.1K | Buy |
1,122
+286
| +34% | +$9.21K | 0.01% | 177 |
|
|
2022
Q4 | $15.4K | Buy |
836
+152
| +22% | +$2.81K | 0.01% | 193 |
|
|
2022
Q3 | $18K | Buy |
+684
| New | +$18K | 0.01% | 162 |
|